Abstract:The PI3 K/Akt signaling pathway controls a wide spectrum of key cellular functions, including cell proliferation and differentiation. The central player Akt is activated by lipid PIP3, which generated by PI3 K and inactivated by tumor suppressor PTEN. Excessive PI3 K/Akt activity or loss of PTEN is often associated with tumorigenesis. Subsequently, full activation of Akt requires its phosphorylation at T308 and S473 by PKD and mTOR, respectively. Recently, we identified a novel protein phosphatase POA as a negative regulator of Akt in a functional genomic screen. Since the PI3 K/Akt signaling is tightly regulated, we hypothesize that POA regulates cellular functions through dephosphorylating Akt. Hence, it is vitally important to investigate the underlying mechanisms and functions for how POA regulates Akt signaling. Objective: (1) To determine whether POA physically interacts with and dephosphorylates Akt, and (2) to investigate how the POA-mediated dephosphorylation terminates the functions of Akt. Methods: We undertook a genome-wide functional genomic screen to identify phosphatases that directly dephosphorylated Akt. Akt phosphorylation in response to insulin or other growth factors was analyzed in normal and tumor cells using immunological methods such as immunoprecipitation (IP), western blotting, immunofluorescence and fluorescence resonance energy transfer (FRET). Effects of POA overexpression and POA knockdown on the level of Akt dephosphorylation were determined by anti-phospho-Akt Western blotting. Real-time PCR and transcriptional analyses of Akt target genes were carried out to determine the functions of POA in regulating Akt responses. POA and its phosphatase-dead mutant were examined for their ability to dephosphorylate Akt, and to affect cell proliferation. Cell proliferation was measured by MTT assays and 3H-thymidine incorporation, and apoptosis detected by caspase cleavage. Muscle differentiation was analyzed in C2C12 myoblasts via myofiber staining. Results: In response to insulin or PDGF, Akt became phosphorylated at T308 and S473. A functional genomic screen identified a novel phosphatase termed POA as a potential Akt phosphatase. Increased expression of POA, but not its phosphatase-dead mutant, abolished growth factor-induced phosphorylation in multiple assays (e.g. IP-Western and FRET). We found that POA could directly interact with Akt in cells and in vitro, and this interaction occurred in the cytoplasm. Importantly, the ability of POA to dephosphorylate Akt was reflected by the functional consequence of POA overexpression or knockdown, which influenced cell proliferation, survival and myoblast differentiation. Conclusion: POA is a novel regulator of the critical PI3 K/Akt signaling pathway. It is conceivable that manipulation of POA activity may provide a platform of intervening the activity of Akt during cancer development.

Protein Phosphatase 2A Isoforms Utilizing Aβ Scaffolds Regulate Differentiation through Control of Akt Protein

Transcriptional Regulation of Pp2a-A Alpha is Mediated by Multiple Factors Including Ap-2 Alpha, Creb, Ets-1, and Sp-1

Protein Phosphatase 2a: Its Structure, Function and Activity Regulation

Protein Phosphatase 2A Has an Essential Role in Promoting Thymocyte Survival During Selection

Reduction of protein phosphatase 2A (PP2A) complexity reveals cellular functions and dephosphorylation motifs of the PP2A/B′δ holoenzyme

Protein Phosphatase 2a (Pp2a) Is Essential For Cd8+T Cell Mediated Anti-Tumor Immunity

Regulatory B Subunits of Protein Phosphatase 2A Are Involved in Site-specific Regulation of Tau Protein Phosphorylation

Progress on Regulation of Protein Phosphatese 2A by Alpha4

Protein phosphatase-2A inhibitor-2 up-regulates p53 and Akt-implication for a new mechanism for Alzheimer's neurodegeneration

Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia

The PP2A-Aβ Gene is Regulated by Multiple Transcriptional Factors Including Ets-1, SP1/SP3, and RXRα/β.

Altering phosphorylation in cancer through PP2A modifiers

PP2A-Mediated Anticancer Therapy.

The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer

PP2A phosphatase regulatory subunit PPP2R3C is a new positive regulator of the hedgehog signaling pathway

IC‐P‐100: Protein Phosphatase‐2a Inhibitor‐2 Up‐regulates P53 and Akt‐implication for a New Mechanism for Alzheimer Neurodegeneration

Ppb Is A Novel Serine/Threonine Phosphatase Of Akt And Is Involved In Myogenesis

Identification of POA as a Novel Phosphatase of Akt Kinase in a Genome-Wide Functional Genomic Screen

Delivery of AKT1 phospho‐forms to human cells reveals differential substrate selectivity

Class IA PI3K isoforms lead to differential signalling downstream of PKB/Akt

PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines.